524394 Stock Overview Provides contract research and testing services in India and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Vimta Labs Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Vimta Labs Historical stock prices Current Share Price ₹991.45 52 Week High ₹1,070.55 52 Week Low ₹390.60 Beta 0.59 1 Month Change 26.46% 3 Month Change 74.27% 1 Year Change 152.76% 3 Year Change 154.19% 5 Year Change 989.51% Change since IPO 90,031.82%
Recent News & Updates
Vimta Labs Limited Announces Resignation of Rama Narahai Naidu Dodda as Chief Financial Officer, Effective 10 December 2024 Dec 04
Insider recently sold ₹5.8m worth of stock Dec 03
Investor sentiment improves as stock rises 21% Nov 26
New minor risk - Insider selling Nov 21
Insider recently sold ₹3.8m worth of stock Nov 21
Second quarter 2025 earnings released: EPS: ₹7.68 (vs ₹2.85 in 2Q 2024) Nov 09 See more updates
Vimta Labs Limited Announces Resignation of Rama Narahai Naidu Dodda as Chief Financial Officer, Effective 10 December 2024 Dec 04
Insider recently sold ₹5.8m worth of stock Dec 03
Investor sentiment improves as stock rises 21% Nov 26
New minor risk - Insider selling Nov 21
Insider recently sold ₹3.8m worth of stock Nov 21
Second quarter 2025 earnings released: EPS: ₹7.68 (vs ₹2.85 in 2Q 2024) Nov 09
New minor risk - Share price stability Nov 08
Investor sentiment improves as stock rises 21% Nov 08
Vimta Labs Limited to Report Q2, 2025 Results on Nov 08, 2024 Nov 05
Thyrocare Technologies Limited (BSE:539871) completed the acquisition of Diagnostics and and pathological services business of Virnta Labs Limited from Vimta Labs Limited (BSE:524394) for INR 70 million. Oct 12
Thyrocare Technologies Limited (BSE:539871) completed the acquisition of Diagnostics and and pathological services business of Virnta Labs Limited from Vimta Labs Limited (BSE:524394) for INR 70 million. Oct 11
New minor risk - Insider selling Sep 19
Investor sentiment improves as stock rises 17% Aug 28
Vimta Labs Limited Approves Dividend for the Year Ended March 31, 2024 Jul 18
Vimta Labs Limited to Report Q1, 2025 Results on Jul 17, 2024 Jul 12
Upcoming dividend of ₹2.00 per share Jul 05
Insider recently sold ₹3.5m worth of stock Jun 28
Full year 2024 earnings released: EPS: ₹18.51 (vs ₹21.77 in FY 2023) Jun 26
Vimta Labs Limited, Annual General Meeting, Jul 18, 2024 May 23
Full year 2024 earnings released: EPS: ₹18.51 (vs ₹21.77 in FY 2023) May 19
Investor sentiment improves as stock rises 23% Apr 25
Investor sentiment deteriorates as stock falls 15% Mar 13
President recently sold ₹982k worth of stock Feb 28
Third quarter 2024 earnings released: EPS: ₹4.57 (vs ₹4.62 in 3Q 2023) Feb 01
Vimta Labs Limited to Report Q3, 2024 Results on Jan 31, 2024 Jan 20
Second quarter 2024 earnings released: EPS: ₹2.85 (vs ₹5.97 in 2Q 2023) Nov 01
Investor sentiment deteriorates as stock falls 16% Oct 26
Investor sentiment improves as stock rises 17% Aug 18
Insider recently sold ₹4.9m worth of stock Aug 13
First quarter 2024 earnings released: EPS: ₹5.51 (vs ₹5.45 in 1Q 2023) Jul 29
Investor sentiment improves as stock rises 19% Jul 14
Vimta Labs Limited Declares Dividend for the Financial Year Ended March 31, 2023 Jun 29
Upcoming dividend of ₹2.00 per share at 0.5% yield Jun 14 Vimta Labs Limited to Report Q4, 2024 Results on May 30, 2024
Full year 2023 earnings released: EPS: ₹21.77 (vs ₹18.70 in FY 2022) May 05 Vimta Labs Limited Recommends Dividend for the Financial Year 2022-2023
Investor sentiment deteriorates as stock falls 16% Feb 03
Third quarter 2023 earnings released: EPS: ₹4.62 (vs ₹5.28 in 3Q 2022) Jan 30
President recently sold ₹2.3m worth of stock Nov 26
Insufficient new directors Nov 16
Investor sentiment improved over the past week Nov 08
Insider recently sold ₹16m worth of stock Nov 05
Insufficient new directors Aug 02
First quarter 2023 earnings released: EPS: ₹5.45 (vs ₹3.65 in 1Q 2022) Jul 26
Investor sentiment improved over the past week Jun 28
Upcoming dividend of ₹2.00 per share Jun 09 Vimta Labs Limited Recommends Dividend for the Financial Year Ended March 31, 2022
Full year 2022 earnings released: EPS: ₹18.70 (vs ₹9.68 in FY 2021) May 15
Vimta Labs Limited Recommends Dividend for the Year 2021-2022 May 14
Vimta Labs Limited, Annual General Meeting, Jun 25, 2022 May 13
Vimta Labs Limited to Report Q4, 2022 Results on May 12, 2022 May 05
Investor sentiment improved over the past week Apr 05
Investor sentiment deteriorated over the past week Feb 24
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Jan 22
Investor sentiment improved over the past week Dec 06
Investor sentiment improved over the past week Oct 30
Second quarter 2022 earnings released: EPS ₹4.41 (vs ₹3.41 in 2Q 2021) Oct 24
First quarter 2022 earnings released: EPS ₹3.65 (vs ₹0.88 loss in 1Q 2021) Jul 23
Investor sentiment improved over the past week Jul 09
Upcoming dividend of ₹2.00 per share Jun 18
Full year 2021 earnings released: EPS ₹9.68 (vs ₹3.10 in FY 2020) Jun 13
Investor sentiment improved over the past week Jun 09
Full year 2021 earnings released: EPS ₹9.68 (vs ₹3.10 in FY 2020) May 16
Vimta Labs Limited Recommends Dividend for the Year 2020-2021 May 15
Investor sentiment improved over the past week Apr 26
Investor sentiment improved over the past week Apr 10
New 90-day low: ₹160 Mar 08
Chief Financial Officer has left the company Feb 03
Vimta Labs Limited Announces Executive Changes Jan 24
Vimta Labs Limited to Report Q3, 2021 Results on Jan 23, 2021 Jan 14
Market bids up stock over the past week Dec 04
New 90-day high: ₹147 Dec 02
First half earnings released Oct 16
New 90-day high: ₹139 Oct 16
Vimta Labs Limited Recommends No Dividend for the Year 2019-2020 Aug 15
First quarter earnings released Aug 11
New 90-day high - ₹98.50 Jul 29 Shareholder Returns 524394 IN Life Sciences IN Market 7D 8.1% -1.8% -0.9% 1Y 152.8% 50.0% 22.5%
See full shareholder returns
Return vs Market: 524394 exceeded the Indian Market which returned 22.5% over the past year.
Price Volatility Is 524394's price volatile compared to industry and market? 524394 volatility 524394 Average Weekly Movement 8.6% Life Sciences Industry Average Movement 6.3% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.1% 10% least volatile stocks in IN Market 4.1%
Stable Share Price: 524394's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 524394's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company Founded Employees CEO Website 1984 1,428 Harita Vasireddi vimta.com
Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, central lab, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; a testing laboratory for water, alcoholic, and non-alcoholic beverages; and clinical diagnostic services to patients, clinicians, hospitals, and central lab services to support clinical research studies.
Show more Vimta Labs Limited Fundamentals Summary How do Vimta Labs's earnings and revenue compare to its market cap? 524394 fundamental statistics Market cap ₹22.02b Earnings (TTM ) ₹493.32m Revenue (TTM ) ₹3.38b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 524394 income statement (TTM ) Revenue ₹3.38b Cost of Revenue ₹942.90m Gross Profit ₹2.43b Other Expenses ₹1.94b Earnings ₹493.32m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 22.21 Gross Margin 72.07% Net Profit Margin 14.61% Debt/Equity Ratio 3.4%
How did 524394 perform over the long term?
See historical performance and comparison Dividends
0.2% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/18 23:48 End of Day Share Price 2024/12/18 00:00 Earnings 2024/09/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Vimta Labs Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Rohit Bhat Batlivala & Karani Securities India Pvt. Ltd. Vijay Madunala FirstCall Research
Show 0 more analysts 
